ライフサイエンスコーパス: total pancreatectomy

1 from 7.3% (distal pancreatectomy) to 22.9% (total pancreatectomy).

2 e criteria underwent PD (47 head only and 10 total pancreatectomy).

3 duodenectomies, 4 distal pencreatectomies, 7 total pancreatectomies).

4 it may play a role in diabetes secondary to total pancreatectomy.

5 dependence compared with those who underwent total pancreatectomy.

6 nts had Whipple procedure and 7 patients had total pancreatectomy.

7 ccessful islet isolation after near-total or total pancreatectomy.

8 endoscopic or surgical means, and partial or total pancreatectomy.

9 IK and an IK in place for 3 months underwent total pancreatectomy.

10 ic head were treated by regional subtotal or total pancreatectomy.

11 r pen therapy) in 12 adult outpatients after total pancreatectomy.

12 ent pancreaticoduodenectomies, 15% underwent total pancreatectomies, 10% underwent distal pancreatect

13 There were 183 total pancreatectomies, 113 partial pancreatoduodenectom

14 Two patients had total pancreatectomy, 2 had distal pancreatectomy, and t

15 nectomies, 10 distal pancreatectomies, and 1 total pancreatectomy; 21 total specimens were obtained.

16 n and 5-year survival were good for standard total pancreatectomies (28.6 months and 24.3%, respectiv

17 , three animals bearing TIK and IK underwent total pancreatectomy 3 months following islet transplant

18 eatoduodenectomy was performed, 4% underwent total pancreatectomy, 4% underwent radiofrequency ablati

19 eatectomy (13), pancreatic enucleation (10), total pancreatectomy (5), Appleby resection (4), and Fre

20 ile operative morbidity was higher following total pancreatectomy (69.0% vs. 38.6% for pancreaticoduo

21 A similar proportion of total pancreatectomy (74.7%) and pancreaticoduodenectomy

22 fter partial pancreatectomy (18/27; 67%) and total pancreatectomy (8/13; 62%) and occurred within 3 y

23 allogeneic islet transplantation as well as total pancreatectomy alone (nontransplanted group).

24 ections reflect the invasiveness of extended total pancreatectomies and the underlying advanced malig

25 onic pancreatitis recipients 1-8 years after total pancreatectomy and autoislet transplantation.

26 analyze factors predicting outcomes after a total pancreatectomy and islet autotransplantation (TP-I

27 ue, complications, and long-term outcomes of total pancreatectomy and islet autotransplantation (TP-I

28 Total pancreatectomy and islet autotransplantation is an

29 Total pancreatectomy and islet autotransplantation provi

30 Total pancreatectomy and islet cell autotransplantation

31 Total pancreatectomy and large regional excisions did no

32 Total pancreatectomy and marginal mass islet autotranspl

33 Total pancreatectomy and pancreaticoduodenectomy patient

34 with chronic pancreatitis who had undergone total pancreatectomy and successful intrahepatic islet a

35 resections (51 pancreaticoduodenectomies, 18 total pancreatectomies, and 49 distal splenopancreatecto

36 ent an operation (6 distal pancreatectomy, 4 total pancreatectomy, and 4 pancreaticoduodenectomy); al

37 atient was unresectable, 6 (10%) underwent a total pancreatectomy, and 56 (89%) had a partial pancrea

38 esected via pancreaticoduodenectomy, 22% via total pancreatectomy, and 8% via distal pancreatectomy.

39 ntraperitoneal [IP] group, n = 9), following total pancreatectomy, and compared them with the respons

40 xide (DZX), and nine of whom required a near-total pancreatectomy, and one partial pancreatectomy.

41 ransplantation; (4) improving outcomes after total pancreatectomy; and (5) registry considerations fo

42 etion or left pancreatectomy, as indicated); total pancreatectomy as an alternative to high-risk anas

43 d glucose and HbA1c for up to 13 years after total pancreatectomy as treatment for chronic painful pa

44 unction was determined in 173 patients after total pancreatectomy at our center.

45 peptide levels in a retrospective cohort of total pancreatectomy autologous islet transplant patient

46 in chronic pancreatitis subjects undergoing total pancreatectomy (autologous islet transplantation).

47 27; P < .001) and operative characteristics (total pancreatectomy: coefficient, 12 742.31; 95% CI, 10

48 were performed in pancreatic specimens after total pancreatectomy due to complications and after plac

49 Patients using the BIHAP after total pancreatectomy experienced an increased percentage

50 Clinical outcomes for total-pancreatectomy followed by intraportal islet autot

51 A total of 434 consecutive total pancreatectomies for primary pancreatic or periamp

52 Total pancreatectomy for presumed painful chronic pancre

53 lycemia in patients undergoing near-total or total pancreatectomy for severe chronic pancreatitis.

54 ctomy, 2 with central pancreatectomy, 1 with total pancreatectomy) for failure to progress (14) and b

55 r in the Whipple procedure group than in the total pancreatectomy group (median survival 19 months vs

56 Four of six patients with total pancreatectomy had islet yields exceeding 5000 isl

57 The role of total pancreatectomy has historically been limited due t

58 prevention of diabetes in patients requiring total pancreatectomy if the pancreas is not extensively

59 Standard total pancreatectomy, if needed, is associated with good

60 odenectomy was performed in 71% of patients, total pancreatectomy in 15%, distal pancreatectomy in 12

61 Sequelae are from diabetes, provided total pancreatectomy is avoided.

62 Glucose control in patients after total pancreatectomy is problematic because of the compl

63 After total pancreatectomy, islets were isolated by using a tw

64 resection with additional resection or even total pancreatectomy may be associated with improved sur

65 Total pancreatectomy may be required in locally advanced

66 etween 1970 and 2007, patients who underwent total pancreatectomy (n = 100) or pancreaticoduodenectom

67 n follow-up, 37 months); none recurred after total pancreatectomy (n = 13; median follow-up, 32 month

68 her pancreatoduodenal resection (n = 103) or total pancreatectomy (n = 2).

69 ), distal pancreatectomy (n = 62; 10.6%), or total pancreatectomy (n = 7; 1.2%).

70 aged 4-6 months, underwent partial (n=4), or total pancreatectomy (n=11), and transplantation of auto

71 = 77 (75%)], tail resections [n = 16 (15%)], total pancreatectomies [n = 5 (5%)], and segment resecti

72 tients had tumor resection (19 Whipple, four total pancreatectomy, one distal pancreatectomy).

73 However, total pancreatectomy operative mortality decreased over

74 the complexities of chronic pancreatitis and total pancreatectomy outcomes and postsurgical diabetes

75 Total pancreatectomy patients had larger median tumor si

76 Total pancreatectomy patients had more lymph nodes harve

77 Total pancreatectomy perioperative mortality dramaticall

78 ticoduodenectomy, distal pancreatectomy, and total pancreatectomy, remain the only potentially curati

79 ibuted to restoration of normoglycemia, near-total pancreatectomy resulted in hyperglycemia, suggesti

80 Total pancreatectomy should be performed when oncologica

81 For patients who had total pancreatectomy, the quantity of infused islets and

82 ncreatectomy to isolate autologous islets or total pancreatectomy to isolate minor antigen-mismatched

83 cent randomized trial advocated prophylactic total pancreatectomy (TP) as alternative aiming to lower

84 To investigate the impact of total pancreatectomy (TP) on oncological outcomes for pa

85 Total pancreatectomy (TP) removes the source of the pain

86 ility of morbidity and mortality rates after total pancreatectomy (TP) reported by different surgical

87 sk following pancreaticoduodenectomy (PD) or total pancreatectomy (TP) with venous resection (VR).

88 Long-term survival following total pancreatectomy versus pancreaticoduodenectomy was

89 ositive resection margins (22.2% vs. 43.7%) (total pancreatectomy vs. pancreaticoduodenectomy, respec

90 ) and perineural invasion (90.7% vs. 91.8%) (total pancreatectomy vs. pancreaticoduodenectomy, respec

91 Total pancreatectomy was associated with higher 30-day m

92 Total pancreatectomy was associated with peptic ulcerati

93 Total pancreatectomy was increasingly used over time (19

94 Extended total pancreatectomies were performed in 54% of cases, w

95 Four patients who developed diabetes after total pancreatectomy were candidates for the autologous

96 Total pancreatectomy with intraportal islet autotranspla

97 Total pancreatectomy with islet autotransplantation (TP-

98 al glycemic HbA1c control (HbA1c 6.5%) after total pancreatectomy with islet autotransplantation (TP-

99 ading to suboptimal endocrine function after total pancreatectomy with islet autotransplantation (TPI

100 after islet infusion in patients undergoing total pancreatectomy with islet autotransplantation (TPI

101 Total pancreatectomy with islet autotransplantation (TPI

102 Total pancreatectomy with islet autotransplantation (TPI

103 ocused on research gaps and opportunities in total pancreatectomy with islet autotransplantation (TPI

104 tive pain but has not been widely applied to total pancreatectomy with islet autotransplantation (TPI

105 or islet yield, and metabolic outcomes after total pancreatectomy with islet autotransplantation (TPI

106 In total pancreatectomy with islet autotransplantation (TPI

107 Total pancreatectomy with islet autotransplantation is p

108 with hereditary and idiopathic CP undergoing total pancreatectomy with islet autotransplantation.

109 The patient underwent total pancreatectomy with splenectomy.